Quality of life

DVS and quality of life

In the latest issue of the American Journal of Ophthalmology, Wagle and associates present interesting new information about the negative impact symptomatic degenerative vitreous floaters have on the quality of life of sufferers.

As Sebag notes in his discussion article in the same edition, investigators found that these patients were willing to take an 11% risk of death and a 7% risk of blindness to get rid of symptoms related to floaters.

Syndicate content

Charity cards

Help raise the profile of eye floaters with One Clear Vision charity cards Christmas box sets now on sale. Visit the online shop.

Research survey

Please take 10 minutes to complete our online survey and add to our research base.

Get involved

One Clear Vision needs you. Find out how you can help.

English

Donate to OCV

Donate to One Clear Vision and help improve the prospects of sufferers of eye floaters

Members of VISION 2020 UK

One Clear Vision is a member of the umbrella group, VISION 2020 UK The Right to Sight

Physician Directory

View our list of ophthalmologists sympathetic to treating vitreous opacities

Poll

What would you be prepared to pay for an effective drug targeted at the symptomatic relief of floaters?
Up to $1000 per year
11%
$2000 per year
7%
$3000 per year
7%
Over $3000 per year
75%
Total votes: 28

Community

Be part of the worldwide eye floater community and add yourself to our world map
Whether you are a sufferer or an interested party, plant your flag on our worldwide map.

Eye on Floaters

Click below for the award winning Helen Keller video on eye floaters

Award winning Helen Keller video